FDA Approved: MYFEMBREE — Supplemental Application (Sumitomo Pharma America, Inc)

View source ↗

Summary

FDA approved a supplemental application for MYFEMBREE, a relugolix/estradiol hemihydrate/norethindrone acetate combination, expanding its labeling or indication…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis
• Uterine Fibroids

Drugs mentioned

• MYFEMBREE (relugolix, estradiol hemihydrate, and norethindrone acetate)

Snippet

SUPPL AP for MYFEMBREE (RELUGOLIX, ESTRADIOL HEMIHYDRATE, AND NORETHINDRONE ACETATE)